Abstract 1467: Development of a HER2-based GEDI microfluidic device for the molecular characterization of CTCs from metastatic breast cancer patients.
2012 ◽
2015 ◽
Keyword(s):
2015 ◽
2010 ◽
Vol 129
(2)
◽
pp. 417-423
◽
2002 ◽
Vol 38
(11)
◽
pp. S74
◽
Keyword(s):